Kala Pharmaceuticals (KALA) Reports Q2 Loss of $4.36
Go back to Kala Pharmaceuticals (KALA) Reports Q2 Loss of $4.36| (NASDAQ: KALA) | Delayed: 3.23 -0.31 (8.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.54 | 52 Week High | $ | |||
| Open | $3.36 | 52 Week Low | $ | |||
| Day High | $3.54 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $ | |||
| Volume | 35,899 | |||||

